From the helm: Amplia Therapeutics (ASX:ATX), CEO & MD, Christopher Burns & Bell Potter Analyst, Thomas Wakim.
From the helm: Amplia Therapeutics (ASX:ATX), CEO & MD, Christopher Burns & Bell Potter Analyst, Thomas Wakim.
Weekly Wrap 17 January: Earnings Season looms as ASX navigates inflation & unemployment data Blog Post
Weekly Wrap 10 January: Inflation, retail sales & unemployment rate drive outlook ahead of RBA meeting in January Blog Post